Conference Reports for NATAP

AASLD 61th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2010 Back

IMO-2125, a TLR9 Agonist, Induces Immune ResponsesWhich Correlate With Reductions In Viral Load In Null Responder HCV Patients       Reported by Jules Levin AASLD Nov 1 2010 Boston   M Rodriguez-Torres, RH Ghalib, SC Gordon, E Lawitz,K Patel, R Pruitt, AM Sheikh, RD Arbeit, AS Bexon, ER Kandimalla, M Precopio, T Sullivan, AJ Muir, JG McHutchison